F-group (family)
2004.1.1.33 Helicase_C,RecQ_Zn_bind
Ligands and drugs
208
Member domains
100
with ligand contacts (≤ 4 Å)
48.1% of members
69
with DrugDomain annotations
33.2% of members
25
with a DrugBank compound
12.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2004.1.1.33 belongs to X-group 2004 P-loop domains-like, which binds 7.5 ligand superclasses per 20 proteins, narrower than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 14 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 98 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 29 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 7 |
| RY8 | N-(2,3-dimethyl-5-sulfamoylphenyl)-4-(2-methylthiazol-4-yl)benzamide | 6 |
| CL | CHLORIDE ION | 3 |
| Kmetal | POTASSIUM ION | 2 |
| 6SV | 1-cyclohexyl-3-[[(2~{R})-oxolan-2-yl]methyl]urea | 1 |
| A1JJ8 | ~{N}-[1-[(4-fluorophenyl)methyl]-7-methyl-indazol-3-yl]propanamide | 1 |
| A1JJK | 2-ethylsulfanyl-~{N}-[1-[(4-fluorophenyl)methyl]indazol-3-yl]ethanamide | 1 |
| A1JJQ | ~{N}-[1-[(4-fluorophenyl)methyl]-7-methyl-indazol-3-yl]prop-2-enamide | 1 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 1 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 1 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 1 |
| CAmetal | CALCIUM ION | 1 |
| CDmetal | CADMIUM ION | 1 |
| GQP | 1-[(4-fluorophenyl)methyl]benzimidazole | 1 |
| X1L | N-[(1S)-1-cyclopropyl-3-(methanesulfonyl)propyl]-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide | 1 |
| YH8 | 2-[2-(3,6-dihydro-2~{H}-pyran-4-yl)-5-ethyl-7-oxidanylidene-6-[4-(3-oxidanylpyridin-2-yl)carbonylpiperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidin-4-yl]-~{N}-[2-methyl-4-(trifluoromethyl)phenyl]ethanamide | 1 |
| YHC | ~{N}-[2-chloranyl-4-(trifluoromethyl)phenyl]-2-[2-(3,6-dihydro-2~{H}-pyran-4-yl)-5-ethyl-6-[4-(6-methyl-5-oxidanyl-pyrimidin-4-yl)carbonylpiperazin-1-yl]-7-oxidanylidene-[1,2,4]triazolo[1,5-a]pyrimidin-4-yl]ethanamide | 1 |